A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling

Leonardo Schirone1, Maurizio Forte2, Silvia Palmerio1,2

  • 1Department of Medical Surgical Sciences and Biotechnologies, "La Sapienza" University of Rome, Latina, Italy.

Insights

This review details molecular mechanisms driving cardiac remodeling after myocardial infarction. Understanding these pathways is key to developing new heart failure treatments and reducing cardiac complications.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Pathophysiology

Background:

  • Myocardial remodeling alters heart structure and function through processes like myocyte loss, hypertrophy, and fibrosis.
  • Stimuli such as pressure/volume overload and chronic inflammation post-myocardial infarction initiate remodeling.
  • Prolonged cardiac remodeling can lead to heart failure progression.

Purpose of the Study:

  • To review molecular pathways involved in cardiac remodeling, focusing on myocardial infarction.
  • To highlight the role of cell signaling in cardiac remodeling.
  • To discuss gene therapy approaches for modulating cardiac remodeling mediators.

Main Methods:

  • Literature review of molecular mechanisms in cardiac remodeling.
  • Analysis of cell signaling networks.
  • Discussion of gene therapy strategies.

Main Results:

  • Cardiac remodeling involves complex signaling pathways including myocyte loss, hypertrophy, ECM alteration, fibrosis, autophagy defects, metabolic, and mitochondrial dysfunction.
  • Myocardial infarction triggers chronic inflammation contributing to remodeling and heart failure.
  • Gene therapy offers potential for modulating key mediators.

Conclusions:

  • Understanding molecular mechanisms of cardiac remodeling is crucial for developing novel therapeutic strategies.
  • Targeting cell signaling pathways may prevent heart failure progression and reduce cardiac complications.
  • Gene therapy presents a promising avenue for treating cardiac remodeling.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.1K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
478
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
649
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
555